Skip to main content

Table 2 Absolute annual consumption of selected antibiotics (DDDatb) in DDDs and relative annual consumption of antibiotics (RDDDatb) in DDD per 100 bed-days (DBD) at the UHO over the study period

From: Antibiotic consumption and its influence on the resistance in Enterobacteriaceae

  

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

Third- and fourth-generation cephalosporins

DDDatb

3,725.5

4,925

4,742.4

6,065.9

6,447.3

5,504.6

6,019.45

5,981

5,886.13

4,417.88

4,640

4,148.25

RDDDatb

1.01

1.34

1.32

1.57

1.66

1.52

1.74

1.69

1.65

1.27

1.35

1.31

Piperacillin/tazobactam

DDDatb

1,715.20

1,703.60

968.40

1,563.60

1,744.50

2,461.60

1,692.80

2,643.50

2,590.77

3,873.13

4,049.81

3,778.91

RDDDatb

0.46

0.46

0.27

0.41

0.45

0.68

0.49

0.75

0.73

1.11

1.18

1.20

Fluoroquinolones

DDDatb

13,056.50

14,515.40

14,092.80

15,887.60

13,411.90

16,246.20

14,941.70

15,344.60

16,614.40

13,228.50

11,267.10

10,743.10

RDDDatb

3.54

3.96

3.92

4.12

3.46

4.47

4.31

4.33

4.65

3.81

3.28

3.40

Aminoglycosides

DDDatb

8,455

7,928.9

7,468.4

8,879.3

8,121.7

8,183.6

8,338.1

9,915.50

9,555.92

10,625.54

8,418.23

10,437.27

RDDDatb

2.29

2.16

2.08

2.3

2.1

2.25

2.4

2.8

2.68

3.06

2.45

3.31

Total consumption of antibiotics

DDDatb

171,316

172,463

142,822

161,919

146,848

164,857

167,993

184,238

186,943

187,945

192,398

177,030

 

RDDDatb

46.39

47.05

39.73

41.97

37.92

45.38

48.45

51.97

52.34

54.1

55.99

56.09